Anti-tuberculosis activity of biogenic silver nanoparticles synthesized by using aqueous leaf extract of Limonia acidissima L.

International Journal of Pharma and Bio Sciences

Volumn 7, Issue 1, 2016, Pages P89-P97

  Patil, Bheemanagouda N ^a   Taranath, T C ^a  

^a KARNATAK UNIVERSITY   (India)

Author keywords

Apoptosis; HR TEM; Limonia acidissima L.; Silver nanoparticles; Tuberculosis

Indexed keywords

CIPROFLOXACIN; LIMONIA ACIDISSIMA EXTRACT; PLANT EXTRACT; PYRAZINAMIDE; SILVER NANOPARTICLE; STREPTOMYCIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; BACTERIAL GROWTH; BIOSYNTHESIS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; DRUG SYNTHESIS; INCUBATION TIME; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PHYSICAL PARAMETERS; PHYTOCHEMISTRY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY SPECTROMETRY;

EID: 85051686079     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Begum N.A., Mondal S., Basu S., Laskar R.A., Manal D. Biogenic synthesis of Au and Ag nanoparticles using aqueous solutions of Black Tea leaf extracts. Colloid Sur B Biointerface, 71:113-118, (2009).
2. Hulkoti N.I., Taranath T.C. Biosynthesis of nanoparticles using microbes-a review. Colloids Surf B Biointerfaces, 121:474-483, (2014).
3. Stalin D.T., Ganesh K.V., Karthick V., Jini A.K., Govindaraju K. Facile synthesis of silver chloride nanoparticles using marine alga and its antibacterial efficacy. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 120:416-420, (2014).
4. Hyo-Jeoung L., Jae Y.S., Beom S.K. Biological synthesis of copper nanoparticles using Magnolia kobus leaf extract and their antibacterial activity. J Chem Technol Biotechnol, 88:1971-1977, (2013).
5. Veena K.R., Taranath T.C. Synthesis of Biogenic Silver Nanoparticles Using Sesamum laciniatum Klein ex Willd. Int J Pharm Sci Rev Res, 29:221-225, (2014).
6. Senapati S., Ahmad A., Khan M.I., Sastry M., Kumar R. Extracellular Biosynthesis of Bimetallic Au-Ag Alloy Nanoparticles Small, 1:517-520, (2005).
7. Choa K.H., Park J.E., Osaka T., Park S.G. The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochimica Acta, 51:956-960, (2005).
8. Lok C.N., Ho C.M., Chen R., He Q.Y., Yu W.Y., Sun H., Tam P.K., Chiu J.F., Che C.M. Proteomic Analysis of the Mode of Antibacterial Action of Silver Nanoparticles. J Proteome Res, 5:916-924, (2006).
9. 4@Ag nanoparticles. Nanotechnology, 18:604-611, (2007).
10. Hipler U., Elsner P. (Eds): Biofunctional textiles and the skin. In Curr Probl Dermatol. Basel. Karger, 33:144-151, (2006).
11. Bosetti M., Mass A, Tobin E, Cannas M. Silver coated materials for external fixation devices: in vitro biocompatibility and genotoxicity. Biomaterials, 23:887-892, (2002).
12. Prabhu A., Shankar K., Muthukrishnan P., Prabhakaran K. Synthesis and characterization of green metallic silver nanoparticles using aqueous extract of Setaria Verticillata and assessing its antimicrobial activity. Int J Pharm Bio Sci, 6(4):423-429, (2015).
13. Feng Q.L, Wu J., Chen G.Q., Cui F.Z., Kim T.N., Kim J.O. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res, 52:662-668, (2000).
14. World Health Organization Global tuberculosis report. http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf?ua=1 (2014).
15. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring project. JAMA, 282:677-686, (1999).
16. Marais B.J., Lonnroth K., Lawn S.D., Migliori G.B., Mwaba P., Glaziou P., Bates M., Colagiuri R., Zijenah L., Swaminathan S., Memish Z.A., Pletschette M., Hoelscher M., Abubakar I., Hasan R., Zafar A., Pantaleo G., Craig G., Kim P., Maeurer M., Schito M., Zumla A. Tuberculosis comorbidity with communicable and noncommunicable diseases: integrating health services and control efforts. Lancet Infect Dis, 13:436-448, (2013).
17. Irene G.S., Mark L.W. Current Concepts in the Management of Tuberculosis. Mayo Clin Proc, 86(4):348-361, (2011).
18. Bryan Rock R, Michael O., Cristina A.B., Thomas W.M., Phillip K.P. Central Nervous System Tuberculosis: Pathogenesis and Clinical Aspects. Clinical microbiology reviews, 243-261, (2008).
19. du Toit L.C., Pillay V., Danckwerts M.P. Tuberculosis chemotherapy: current drug delivery approaches. Respir Res, 7:118, (2006).
20. Aagaard C., Dietrich J., Doherty M., Andersen P. TB vaccines: current status and future perspectives. Immunol Cell Biol, 87:279-286, (2009).
21. Zahoor A., Rajesh P., Sadhana S., Khuller G.K. Alginate nanoparticles as Antituberculosis Drug Carriers: Formulation Development, Pharmacokinetics and Therapeutic Potential. The Ind J Chest Dis Alli Sci, 48:171-176, (2006).
22. Rajan M., Raj V. Encapsulation, characterization and in-vitro release of anti-tuberculosis drug using chitosan-Poly ethylene glycol nanparticles. Int J Pharma Pharma Sci, 4(4):255-259, (2012).
23. Banu A., Rathod V. Biosynthesis of Monodispersed Silver nanoparticles and their activity against Mycobacterium tuberculosis. J Nanomed Biotherapeut Discov, 3:1-5, (2013).
24. Chatterjee T.K. Herbal Options, 3rd ed. Books and Allied (P) Ltd., Calcutta, 203-256, (2000).
25. Kamat C.D., Khandelwal K.R., Bodhankar S.L., Ambawade S.D., Mhetre N.A. Hepatoprotective activity of leaves of Feronia elephantum Correa (Rutaceae) against carbon tetrachloride induced liver damage in rats. J Natural Remed, 3:148-154, (2003).
26. Bandara B.M.R., Hewage C.M., Jayamanne D.H.L.W., Karunaratne V., Asikaram N.K.B., Bandara K.A.N.P., Wijesundara D.S.A. Biological activity of some steam distillates from leaves of ten species of rutaceous plants. J Natn Sci Coun Sri Lanka, 18:71-77, (1990).
27. Khewkhom N., Greger H., Shangchote S. Antimicrobial activity of 16 plant extracts of the Rutaceae family against phytopathogenic fungi. Agricultural Sci J, 39:119-123, (2008).
28. Adikaram N.K.B., Abhayawardhane Y., Gunatilaka A.A.L., Bandara B.M.R., Wijeratne E.M.K. Antifungal activity, acid and sugar content in the wood apple (Limonia acidissima) and their relation to fungal development. Plant Pathology, 38:258-265, (2007).
29. Kim K.H., Ha S.K., Kim S.Y., Kim S.H., Lee K.R. Limodissimin A: A New dimeric coumarin from Limonia acidissima. Bull Korean Chem Soc, 30:2135-2137, (2009).
30. Gupta R., Johri S., Saxena A.M. Effect of ethanolic extract of Feronia elephantum Correa fruits on blood glucose level in normal and streptozotocin-induced diabetic rats. Natural Product Radiance, 8:32-36, (2009).
31. Joshi R.K., Badakar V.M., Kolkute S.D., Khatib N. Chemical composition and antimicrobial activity of the essential oil of the leaves of Feronia elephantum (Rutaceae) from north west Karnataka. Nat Prod Commun, 6:141-143, (2011).
32. Maria C.S.L., Marcus V.N.D., Alessandra C.P., Marcelle D.L.F., Raoni S.B.G., Thais C.M.N., Monica A.P. Evaluation of anti-Tubercular activity of nicotinic and isoniazid analogues. ARKIVOC, 181-191, (2007).
33. Patra A., Misra S.K., Chaudhury S.K. Constituents of Limonia acidissima application of two dimensional NMR spectroscopy in structure elucidation. Journal of the Indian Chemical Society, 65:205-208, (1988).
34. Jebali A., Ramezani F., Kazemi B. Biosynthesis of Silver Nanoparticles by Geotrichum sp. J Clust Sci, 22:225-232, (2011).
35. Krishnaraj C., Jagan E.G., Rajasekar S., Selvakumar P., Kalaichelvan P.T., Mohan N. Synthesis of silver nanoparticles using Acalypha indica leaf extracts and its antibacterial activity against water borne pathogens. Colloids Surf B Biointerfaces, 76(1):50-56, (2010).
36. Ahmad A., Senapati S., Khan M.I., Kumar R., Sastry M. Extracellular biosynthesis of monodisperse gold nanoparticles by a novel extremophilic actinomycete, Thermomonospora sp. Langmuir, 19:3550-3553, (2003).
37. Dubeya S.P., Lahtinen M., Sillanpaa M. Tansy fruit mediated greener synthesis of silver and gold nanoparticles. Process Biochemistry, 45:1065-1071, (2010).
38. Huang H., Yang X. Synthesis of polysaccharidestabilized gold and silver nanoparticles: a green method. Carbohydrate Research, 339:2627-2631, (2004).
39. Gopinath K., Sundaravadivelan C, Arumugam A. Green synthesis, characterization of silver and bimetallic nanoparticles using bark extract of Terminalia arjuna and their larvicidal activity against malaria vector, Anopheles stphensi. I. J. Recent Scientific Research, 4(6):904-910, (2013).
40. l flowerlike architectures exhibiting antimicrobial activity. J Phys Chem B, 110:205-210, (2006).
41. Patil R.S., Kokate M.R., Salvi P.P., Kolekar S.S. A novel one step synthesis of silver nanoparticles using room temperature ionic liquid and their biocidal activity. C R Chimie, 14:1122-1127, (2011).
42. Priester J., Stoimenov P., Mielke R., Webb S., Ehrhardt C., Zhang J., Stucky G., Holden P. Effects of soluble cadmium salts versus CdSe quantum dots on the growth of planktonic Pseudomonas aeruginosa. Environ Sci Technol, 43:2589-2594, (2009).
43. Patil R.S., Kokate M.R., Kolekar S.S. Bioinspired synthesis of highly stabilized silver nanoparticles using Ocimum tenuiflorum leaf extract and their antibacterial activity. Spectrochimica Acta Part A, 91:234-238, (2012).
44. Brayner R., Ferrari-Iliou R., Brivois N., Djediat S., Benedetti M., Fiévet F. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett, 6:866-870, (2006).
45. Inbakandan D., Kumar C., Stanley A.L., Kirubagaran R., Venkatesan R., Ajmal K.S. Silver nanoparticles with anti microfouling effect: A study against marine biofilm forming bacteria. Colloids and Surfaces B: Biointerfaces, 111:636-643, (2013).
46. Mohanty S., Jena P., Mehta R., Pati R., Banerjee B., Patil S., Sonawane A. Cationic Antimicrobial Peptides and Biogenic Silver Nanoparticles Kill Mycobacteria without Eliciting DNA Damage and Cytotoxicity in Mouse Macrophages. Antimicrobial Agents and Chemotherapy, 57(8):3688-3698, (2013).
47. Yamanaka M., Hara K., Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol, 71:7589-7593, (2005).
48. Kumar A., Kumar-Vemula P., Ajayan P.M., John G. Silver-nanoparticle embedded antimicrobial paints based on vegetable oil. Nat Mater, 7:236-241, (2008).
49. Gupta P., Bajpai M., Bajpai S.K. Investigation of antibacterial properties of silver nanoparticleloaded poly (acrylamide-co-itaconic acid)-grafted cotton fabric. J Cotton Sci, 12:280-286, (2008).
50. Bragg P.D., Rainnie D.J. The effect of silver ions on the respiratory chains of Escherichia coli. Can J Microbiol, 20:883-889, (1974).
51. Sondi I., Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci, 275:177-182, (2004).
52. Hamouda T., Baker Jr. Antimicrobial mechanism of action of surfactant lipid preparations in enteric gram-negative bacilli. J Appl Microbiol, 89:397-403, (2000).
53. Sharma V.K., Yngard R.A., Lin Y. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv. Colloid Interface Sci, 145: 83-96, (2009).
54. Jiang H., Manolache S., Lee Wong C., Denis F.S. Plasma-enhanced deposition of silver nanoparticles onto polymer and metal surfaces for the generation of antimicrobial characteristics. J Appl Polymer Sci, 93:1411-1422, (2004).
55. Azuma I., Yamamura Y. Studies on the firmly bound lipids of human tubercle bacillus. II. Isolation of arabinose mycolate and identification of its chemical structure. J Biochem, 53:275-281, (1963).
56. Takayama K., Armstrong E.L. Metabolic role of free mycolic acids in Mycobacterium tuberculosis. J Bactenol, 130:569-570, (1977).
57. Kilburn J.O., Greenberg J. Effect of ethambutol on the viable cell count in Mycobacterium smegmatis. Antimicrob Agents Chemother, 11:534-540, (1977).
58. Takayama K., Armstrong E.L., Kunugi K.A., Kilburn J.O. Inhibition by ethambutol of mycolic acid transfer into the cell wall ofMycobacterium smegmatis. Antimicrob Agents Chemotherp, 16:240-242, (1979).